Electroporation of Antibodies into Mammalian Cells

  • Paul L. Campbell
  • James McCluskey
  • Jing Ping Yeo
  • Ban-Hock Toh
Part of the Methods in Molecular Biology book series (MIMB, volume 48)


The introduction into mammalian cells of antibodies with specificities for endogenous cellular factors permits the functional assessment of such factors in the context of living cells. Antibodies have been successfully introduced into several cell types by various methods, including fine-needle microinjection (1), osmotic lysis of pinocytotic vesicles (2, 3, 4), liposome-mediated delivery (5), and fusion of red cell ghosts loaded with protein (5, 6, 7, 8). Each of these techniques has its associated drawbacks: Microinjection is very time-consuming and is inappropriate for transfer of antibodies into large numbers of cells; osmotic lysis of pinocytotic vesicles results in massive cell damage and thus requires very large numbers of cells and long recovery periods (4). Red cell ghosts or liposomes require either the use of targeting molecules likely to modify the nature of the target cell membrane (5) or the use of potentially hazardous virus to stimulate fusion (6,7).


Trypan Blue Electroporated Cell Pinocytotic Vesicle Target Cell Membrane Trypan Blue Solution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Arnheiter, H., and Haller, O. (1988) Antiviral state against influenza virus neutralised by microinjection of antibodies to interferon-induced Mx proteins. EMBO J. 7, 1315–1320.PubMedGoogle Scholar
  2. 2.
    Okada, C. Y., and Rechsteiner, M. (1982) Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytotic vesicles. Cell 29, 33–41.PubMedCrossRefGoogle Scholar
  3. 3.
    Morgan, D. O., and Roth, R. A. (1987) Acute insulin action requires insulin receptor kinase activity: introduction of an inhibitory monoclonal antibody into cells blocks the rapid effects of insulin. Proc. Natl. Acad. Sci. USA 84, 41–45.PubMedCrossRefGoogle Scholar
  4. 4.
    Chakrabarti, R., Pfeiffer, N. E., Wylie, D. E., and Schuster, S. M. (1989) Incorporation of monoclonal antibodies into cells by osmotic permeabilization. Effect on cellular metabolism. J. Biol. Chem. 264, 8214–8221.PubMedGoogle Scholar
  5. 5.
    Guyden, J., Godfrey, W., Doe, B., Ousley, F., and Wofsy, L. (1984) Immunospecific vesicle targeting facilitates fusion with selected cell populations. Ciba. Found. Symp. 103, 239–253.PubMedGoogle Scholar
  6. 6.
    Hosoi, T., Ozawa, K., Tsao, C. J., Urabe, A., Uchida, T., and Takaku, F. (1985) Introduction of macromolecules into hemopoietic stem cells with an erythrocyte-ghost-mediated system. Biochem. Biophys. Res. Commun. 128, 193–198.PubMedCrossRefGoogle Scholar
  7. 7.
    Ozawa, K., Hosoi, T., Tsao, C. J., Urabe, A., Uchida, T., and Takaku, F. (1985) Microinjection of macromolecules into leukemic cells by cell fusion technique: search for intracellular growth-suppressive factors. Biochem. Biophys. Res. Commun. 130, 257–263.PubMedCrossRefGoogle Scholar
  8. 8.
    Ohara, J., Sugi, M., Fujimoto, M., and Watanabe, T. (1982) Microinjection of macromolecules into normal murine lymphocytes by means of cell fusion. II Enhancement and suppression of mitogenic responses by microinjection of monoclonal anti-cyclic AMP into B-lymphocytes. J. Immunol. 129, 1227–1232.PubMedGoogle Scholar
  9. 9.
    Chakrabarti, R., Wylie, D. E., and Schuster, S. M. (1989) Transfer of monoclonal antibodies into mammalian cells by electroporation. J. Biol. Chem. 264, 15,494–15,500.PubMedGoogle Scholar
  10. 10.
    Baron, M., Gautier, N., Kaliman, P., Dolais-Kitabgi, J., and Van Obberghen, E. (1991) The carboxyl-terminal domain of the insulin receptor: its potential role in growth-promoting effects. Biochemistry 30, 9365–9370.PubMedCrossRefGoogle Scholar
  11. 11.
    Tanti, J.-F., Gautier, N., Cormont, M., Baron, V., Van Obberghen, E., and Le Marchand-Brustel, Y. (1992) Potential involvement of the carboxy-terminus of the Glut 1 transporter in glucose transport. Endocrinology 131, 2319–2324.PubMedCrossRefGoogle Scholar
  12. 12.
    Yeo, J. P., Alderuccio, F., and Toh, B. H. (1994) A new chromosomal protein essential for mitotic spindle assembly. Nature 367, 288–291.PubMedCrossRefGoogle Scholar
  13. 13.
    Maccarrone, M., Veldink, G. A., and Vliegenthart, J. F. G. (1992) Inhibition of lipoxygenase activity in lentil protoplasts by monoclonal antibodies introduced into the cells via electroporation. Eur. J. Biochem. 205, 995–1001.PubMedCrossRefGoogle Scholar
  14. 14.
    Campbell, P. L., Kulozik, A. E., Woodham, J. P., and Jones, R. W. (1990) Induction by HMBA and DMSO of genes introduced into mouse erythroleukemia and other cell lines by transient transfection. Genes and Dev. 4, 1252–1266.PubMedCrossRefGoogle Scholar
  15. 15.
    Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M., and Strober, W. (eds.) (1992) Current Protocols in Immunology. Wiley, New York.Google Scholar

Copyright information

© Humana Press Inc. 1995

Authors and Affiliations

  • Paul L. Campbell
    • 1
  • James McCluskey
    • 1
  • Jing Ping Yeo
    • 1
  • Ban-Hock Toh
    • 1
  1. 1.Centre for Transfusion Medicine and ImmunologyFlinders Medical CenterBedford ParkAustralia

Personalised recommendations